Microsoft Sell-Off? I'm Buying It!

01:37pm, Thursday, 31'st Oct 2024
Microsoft remains a household name, integral to daily activities even for those outside finance, investing, or technology. I believe recent bearish sentiments and the current sell-off of Microsoft are
OpenAI's Google challenger is finally here. The company on Thursday launched ChatGPT Search, an evolution of the SearchGPT prototype it unveiled this summer. Built into OpenAI's ChatGPT platform, Chat
OpenAI launches ChatGPT web search to rival Google, partners with major publishers, and invests $5 billion in custom AI chips while Microsoft takes $1.5B quarterly hit from its AI investments.

OpenAI Adds Search Engine to ChatGPT

01:00pm, Thursday, 31'st Oct 2024
The popular online chatbot can now access and deliver information from across the internet in real time, including news, stock prices and sports scores.
CNBC's Steve Kovach joins 'Money Movers' to discuss big tech's AI spending.
OpenAI on Thursday launched ChatGPT search, positioning the company to better compete with search engines like Google, Microsoft's Bing and Perplexity. In July, OpenAI announced it was beta-testing a
Microsoft Corporation MSFT analysts saw potential short-term setbacks with capacity constraints and weaker guidance than expected but were also looking at an exciting path for AI monetization ahead af
Shares of Microsoft (MSFT) slid on Thursday after the company's revenue forecast fell short of Wall Street's estimates and the cloud computing giant struggles to meet demand.

OpenAI spending weighs on Microsoft stock

11:32am, Thursday, 31'st Oct 2024
Microsoft (MSFT) stock moves lower after the tech giant reported earnings as artificial intelligence (AI) spending weighs on shares. The company's earnings beat, driven by cloud strength, wasn't enoug
Gil Luria, DA Davidson managing director, joins CNBC's 'Money Movers' to discuss his buy rating on Meta, expectations for how AI will impact earnings, and more.
MSFT beats earnings and revenue estimates but offers downbeat guidance.
According to Dave Sekera with @morningstar, the markets are reacting too harshly to Meta Platforms (META) and Microsoft's (MSFT) earnings. He says both companies are "undervalued" when using Morningst
WARREN, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf
Microsoft's NASDAQ: MSFT price action pulled back into a technical buying opportunity following the FQ1 2025/CQ3 2024 earnings release. The primary culprits are a diminished outlook for Azure growth i

How 2 Big Tech Titans Are Faring After Earnings

10:39am, Thursday, 31'st Oct 2024
Meta Platforms Inc (NASDAQ:META) and Microsoft Corp (NASDAQ:MSFT) are reeling after their highly anticipated earnings reports.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE